2011
DOI: 10.1016/j.thromres.2011.03.012
|View full text |Cite
|
Sign up to set email alerts
|

Successive bleeding and thrombotic complications in a patient with afibrinogenemia: A case report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
12
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 20 publications
0
12
0
Order By: Relevance
“…Managing IFD patients with thrombosis is challenging as they may be at risk of life-threatening hemorrhage [8] or require hemostatic support following surgery, trauma, or childbirth [9,10]. In such situations, clinicians face the difficult task of providing sufficient hemostasis while minimizing the risk of thromboembolism.…”
Section: Introductionmentioning
confidence: 99%
“…Managing IFD patients with thrombosis is challenging as they may be at risk of life-threatening hemorrhage [8] or require hemostatic support following surgery, trauma, or childbirth [9,10]. In such situations, clinicians face the difficult task of providing sufficient hemostasis while minimizing the risk of thromboembolism.…”
Section: Introductionmentioning
confidence: 99%
“…[6] These complications can occur in the presence of concomitant risk factors such as a co-inherited thrombophilic risk factor or after replacement therapy. [7] However, in many patients, no known risk factors are present. Several hypotheses have been put forward to explain this predisposition to thrombosis.…”
Section: Discussionmentioning
confidence: 99%
“…Though there are several reports of both arterial and venous thrombosis in afibrinogenemia,[78] only a few cases have been reported where these patients developed MI. [2] With recurrent MI, this is the first case we are reporting.…”
Section: Discussionmentioning
confidence: 99%
“…Also, because of the precarious balance of the process of hemostasis, thrombolytics and anti-thrombotic treatments could not be used. The use of these treatments classically contraindicated in fibrinogen deficient patients has nevertheless been described in cases of thrombotic complications, often in parallel with fibrinogen infusion [3-5,10]. …”
Section: Discussionmentioning
confidence: 99%
“…Although uncommon, some cases of venous and arterial thrombotic events associated with fibrinogen deficiency have been reported in the literature [1-9]. The mechanism of this apparently paradoxical thrombotic tendency, which has long remained problematic, has now been partially clarified [10]. …”
Section: Introductionmentioning
confidence: 99%